Digest Network Come funziona
Network
/
Società
No
Non verificato

Nocion Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

6 comunicati stampa

Guarda tutti i comunicati
26/01/2026
Associazioni/Professionisti
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Eventi
Nocion Therapeutics to Present Preclinical Data Supporting Nocions™ as a Novel Approach for the Treatment of Pain at the Non-Opioid Pain Therapeutics Summit
Fonte
Nocion Therapeutics, Inc.
Emittente
Business Wire
1.00
0
07/01/2026
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Nocion Therapeutics Extends Series B Financing to $93 Million to Support Late-Stage Development of Taplucainium in Chronic Cough
Fonte
Nocion Therapeutics, Inc.
Emittente
Business Wire
1.00
0
28/04/2025
Mercato del lavoro
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Nocion Therapeutics Appoints Matthew Frankel, M.D., MBA to Chief Medical Officer
Fonte
Nocion Therapeutics, Inc.
Emittente
Business Wire
1.00
0
18/11/2024
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Industria
Nocion Therapeutics Announces First Patient Dosed in ASPIRE Phase 2b Chronic Cough Study
Fonte
Nocion Therapeutics, Inc.
Emittente
Business Wire
1.00
0
15/07/2024
Eventi
Industria
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Nocion Therapeutics Presents Data on Preclinical and Clinical Development of Taplucainium, a Novel, Charged Sodium Channel Blocker, as a potential treatment for Chronic Cough at the 13th London International Cough Symposium
Fonte
Nocion Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/07/2024
Mercato del lavoro
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Nocion Therapeutics Appoints Dr. Catherine Bonuccelli to Scientific Advisory Board and Joan Shaw to Senior Vice President, Clinical Operations
Fonte
Nocion Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0